Moderna Inc. (MRNA): Price and Financial Metrics
MRNA Price/Volume Stats
| Current price | $30.49 | 52-week high | $129.39 |
| Prev. close | $30.28 | 52-week low | $23.15 |
| Day low | $30.20 | Volume | 6,972,600 |
| Day high | $30.94 | Avg. volume | 11,273,059 |
| 50-day MA | $26.70 | Dividend yield | N/A |
| 200-day MA | $38.22 | Market Cap | 11.79B |
MRNA Stock Price Chart Interactive Chart >
Moderna Inc. (MRNA) Company Bio
Moderna, Inc. (/məˈdɜːrnə/ mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to produce an immune response. (Source:Wikipedia)
MRNA Price Returns
| 1-mo | 16.73% |
| 3-mo | 21.43% |
| 6-mo | -28.38% |
| 1-year | -74.23% |
| 3-year | -80.89% |
| 5-year | -48.45% |
| YTD | -26.67% |
| 2024 | -58.19% |
| 2023 | -44.63% |
| 2022 | -29.28% |
| 2021 | 143.11% |
| 2020 | 434.10% |
Loading social stream, please wait...